The augmented writing platform has now raised almost $30m since it was founded, having attracted Bloomberg Beta for a third successive round.

The digital currency technology developer has raised $40m in a round co-led by GV and backed by Virgin which will support global expansion and R&D.

Tengelmann Ventures, which previously took part in the digital wealth manager's series A round last year, has returned for a $33.5m series B.

Baxalta-backed Syntimmune has raised $50m in an Apple Tree Partners-led series B round that will fund clinical development of its autoimmune diseases treatment.

Industrial internet-of-things technology developer Augury has now raised $26m altogether, after Munich Re/HSB Ventures co-led its latest round.

The eye disease treatment developer has raised $7.5m in a round co-led by pharmaceutical company Abdi Ibrahim, six months after closing a $6m series A.

The TV analytics software provider has raised new funding from investors including MDC Partners, Interpublic Group, A+E Networks and Time Warner.

AI sales support technology developer Highspot has now raised almost $25m in equity funding, in the process adding Salesforce Ventures as a new investor.

The open source software management company has secured $10m in a Microsoft Ventures-backed round led by 83North.

Novel TMT Ventures returned for a $22.5m round that increased the excess inventory sales platform's overall funding to $36m.